Shlomo Shalev joined our Board of Directors in December 2024. Shlomo is the Chair of the Board of GFC Greenfields Capital (TASE), and the CEO of XTL Biopharmaceuitcals (TASE and Nasdaq). Prior to that Shlomo has led a number of private and public companies including Intercure, Micronet, NetfroX as well as serving on many public and private companies board of directors including OphirOptronics, Arel Communication, Granit Hacramel and PowerDsine. Shlomo has gained extensive  business experience in venture funding, private invesments, M&A’s  and turn-around situations.

With an educational background in economics, Mr. Shalev was Israel’s Consul for Economic Affairs in the U.S. North Wesstern Region and the Economic Advisor to the Director General of the Ministry of Industry and Trade.

Mr. Shalev holds an MBA from the University of San Francisco and a B.A. degree in Economics from the University of Ben Gurion, Beer Sheva, Israel.